BNTX
BioNTech SE
NASDAQ · Healthcare · Biotechnology · DE
$103.76
+0.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.26x
- Price / sales
- 8.48x
- Price / cash flow
- 30.43x
Enterprise value
- Enterprise value
- $15.1B
- EV / sales
- 4.92x
- EV / EBITDA
- -13.81x
- EV / EBIT
- -6.85x
- Market cap
- $26.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026